Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-ITP: Rituximab in Primary Immune Thrombocytopenia
jRCT1091220070Completed
- Sponsor
- Keio University School of Medicine
- Start
- Aug 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of rituximab in immune thrombocytopenia (ITP), sponsored by Keio University School of Medicine. Started Aug 2011; status: completed.
02
Drugs
rituximab
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on jRCT1091220070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220070.